Advertisement

Topics

Chroma Therapies Company Profile

15:45 EST 23rd January 2019 | BioPortfolio


News Articles [287 Associated News Articles listed on BioPortfolio]

Aved's New Custom High-Reliability Battery Solutions Receive Dedicated Testing from Chroma Model 17020 System

Providing robust end-of-line testing, Aved utilizes their new Chroma Model 17020 Regenerative Battery Pack Test System which supports dedicated repetitive charge and discharge tests on multiple batte...

CAR T-Cell Therapies Show Durable Responses, New Research Also Explores Combination Therapies ...

SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types Read more...

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

Chroma Therapeutics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryChroma Therapeutics Ltd Chroma Therapeutics is a biotechnology company that discovers and develops small molecule drugs based on chromatin biology and novel cell accumulation approaches. The co...

CAR T-Cell Therapies Moving to Outpatient Setting

The high durable response rates seen with CAR T-cell therapies have helped fill a high unmet need for patients with relapsed/refractory diffuse large B-cell lymphoma, with questions remaining on the o...

PhRMA Highlights Impact of Cell and Gene Therapies in New Report

This morning the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that shows there are nearly 300 novel cell and gene therapies currently in development throughout the in...

New Adjunctive Therapies for Coronary Artery Disease?

Rivaroxaban and icosapent ethyl are potential add-on therapies.

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Byetta [AstraZeneca Pharmaceuticals LP]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA® (exenatide) injection, for subcutaneous useInitia...

PubMed Articles [557 Associated PubMed Articles listed on BioPortfolio]

Effective Content-aware Chroma Reconstruction Method for Screen Content Images.

In this paper, we propose an effective novel contentaware chroma reconstruction (CACR) method for screen content images (SCIs). After receiving the decoded downsampled YUV image on the client side, ou...

The effect of dietary carotenoid increase on painted turtle spot and stripe color.

Determination of how carotenoid-based color patches change with pigmentary access is important to understanding color patch function in animals. We performed a carotenoid addition experiment on male p...

The identification of dark cutting beef carcasses in Australia, using Nix Pro Color Sensor™ colour measures, and their relationship to bolar blade, striploin and topside quality traits.

Within 24 h post-mortem, loin surfaces of Australian beef carcasses (n = 436) were evaluated using the Nix Pro Color Sensor™ (NIX). The potential for colorimetrics (L*, a*, b*, hue and chroma)...

Preference and Perception of Enhanced Images During Endonasal Endoscopic Surgery.

Image enhancement is used widely in endoscopic sinonasal surgery. It is yet to be established whether image enhancement has advantages over white-light endoscopy. The authors aimed to evaluate the pre...

Emerging therapies for mitochondrial diseases.

For the vast majority of patients with mitochondrial diseases, only supportive and symptomatic therapies are available. However, in the last decade, due to extraordinary advances in defining the cause...

Clinical Trials [1703 Associated Clinical Trials listed on BioPortfolio]

Randomized Clinical Trial of Occlusal Sealant

This study assessed long-term impact of tooth Eruption Stages (ES) on sealant retention on occlusal surfaces previously coated with intermediary bonding layer and it determined caries inci...

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA)

This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injection...

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

The purpose of this study is to observe and describe treatment patterns, like Overactive Bladder (OAB) treatment discontinuation, switching to other therapies and persistence of OAB therap...

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Companies [890 Associated Companies listed on BioPortfolio]

Chroma Therapies

Chroma Technology Corp

Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pa...

Chroma Therapeutics Ltd

Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology. Chroma is the first company to system...

Chroma Technology Corp.

Toler RX Incorporated

TolerRx, Inc. is an emerging biopharmaceutical enterprise specializing in the discovery, development, and commercial launch of a novel class of therapies that induce and/or maintain immunological tole...

More Information about "Chroma Therapies" on BioPortfolio

We have published hundreds of Chroma Therapies news stories on BioPortfolio along with dozens of Chroma Therapies Clinical Trials and PubMed Articles about Chroma Therapies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chroma Therapies Companies in our database. You can also find out about relevant Chroma Therapies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record